Clinical trial · Interventional
Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a
NCT02381015CI-TRIAL-00041873completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study was designed to compare the efficacy, perception, decision making, and cost-effectiveness of genomic and non-genomic approaches for risk assessment of prostate cancer and for chemoprevention of prostate cancer.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hereditary Prostate Cancer | Hereditary Prostate Carcinoma | ALIAS | 0.90 |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
| Prostate Cancer, Familial | Malignant Prostate Neoplasm | CURATED_EXACT | 0.85 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Family History: Number Format | Behavioral | — | UNRESOLVED |
| Family History: Number + Pictograph | Behavioral | — | UNRESOLVED |
| Genetic Risk Score: Number Format | Genetic | — | UNRESOLVED |
| Genetic Risk Score: Number + Pictograph | Genetic | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- EXPERIMENTAL
- label
- Genetic Risk Score: Number Format
- description
- Genetic Risk Score: Number Format Subjects receive genetic risk scores in a number format.
- interventionNames
- Genetic: Genetic Risk Score: Number Format
- type
- EXPERIMENTAL
- label
- Genetic Risk Score: Number + Pictograph
- description
- Genetic Risk Score: Number + Pictograph Subjects receive genetic risk scores in a number and pictograph format.
- interventionNames
- Genetic: Genetic Risk Score: Number + Pictograph
- type
- EXPERIMENTAL
- label
- Family History: Number Format
- description
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 40 Years
- Maximum age
- 49 Years
Show eligibility criteria text
Inclusion Criteria: * age 40 to 49 years, self-defined Caucasian background, and no prior prostate specific antigen (PSA) screening nor prostate cancer (PCa) diagnosis. Exclusion Criteria: * outside of age range, or not self defined Caucasian background, or a prior history of PSA screening or PCa diagnosis
References
Publications (0)
Data not yet available
No reference posted for this study.